Jens Kringelum

Company: Evaxion Biotech
Job title: Director, Genomic Immuno-Oncology
Seminars:
Current Identification of Neoantigens & How this Translates to Preclinical Settings 12:00 pm
Considering the current overview of identification and prioritisation of cancer neoantigens Highlighting the limitations of current neoantigen prediction pipelines Discussing broader challenges associated with cancer neoantigen vaccinesRead more
day: Track A - Day 1 AM